Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Stendörren Fastigheter in connection with a directed share issue of approximately SEK 505 million
Mandate

Vinge has advised Stendörren Fastigheter in connection with a directed share issue of approximately SEK 505 million

October 25, 2024

Vinge has advised the property company Stendörren Fastigheter AB (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 505 million before transaction costs.

The company intends to use the proceeds to finance growth and to capitalize on investment opportunities within warehouse, logistics and light industrial by completing property acquisitions and investments in project development. The Stendörren Fastigheter share is listed on Nasdaq Stockholm Mid Cap.

Vinge’s team consisted of Jesper Schönbeck, David Andersson, Joel Magnusson, Adrian Filipovic and Louise Nässén.

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025